Genomtec S.A.
GMT.WA · WSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| % Growth | -33.3% | 20% | – | – |
| Cost of Goods Sold | PLN 6 | PLN 3 | PLN 1 | -PLN 0 |
| Gross Profit | -PLN 6 | -PLN 3 | -PLN 1 | PLN 0 |
| % Margin | -143,250% | -51,083.3% | -21,840% | – |
| R&D Expenses | PLN 2 | PLN 1 | PLN 1 | PLN 2 |
| G&A Expenses | PLN 2 | PLN 0 | PLN 2 | -PLN 0 |
| SG&A Expenses | PLN 2 | PLN 1 | PLN 2 | -PLN 0 |
| Sales & Mktg Exp. | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Other Operating Expenses | -PLN 6 | -PLN 2 | -PLN 1 | PLN 0 |
| Operating Expenses | -PLN 3 | PLN 0 | PLN 2 | PLN 2 |
| Operating Income | -PLN 3 | -PLN 4 | -PLN 3 | -PLN 2 |
| % Margin | -62,825% | -71,216.7% | -61,940% | – |
| Other Income/Exp. Net | -PLN 0 | PLN 1 | -PLN 0 | -PLN 0 |
| Pre-Tax Income | -PLN 3 | -PLN 3 | -PLN 3 | -PLN 2 |
| Tax Expense | PLN 0 | PLN 0 | PLN 0 | -PLN 0 |
| Net Income | -PLN 3 | -PLN 3 | -PLN 3 | -PLN 2 |
| % Margin | -64,300% | -55,833.3% | -64,100% | – |
| EPS | -0.17 | -0.23 | -0.22 | -0.14 |
| % Growth | 26.1% | -4.5% | -57.1% | – |
| EPS Diluted | -0.17 | -0.23 | -0.22 | -0.14 |
| Weighted Avg Shares Out | 15 | 15 | 15 | 13 |
| Weighted Avg Shares Out Dil | 15 | 15 | 15 | 13 |
| Supplemental Information | – | – | – | – |
| Interest Income | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Interest Expense | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Depreciation & Amortization | PLN 1 | PLN 1 | PLN 1 | PLN 1 |
| EBITDA | -PLN 2 | -PLN 2 | -PLN 3 | -PLN 1 |
| % Margin | -46,275% | -40,616.7% | -50,300% | – |